APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalamine API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mesalamine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025199 pages

Choose your research edition.

Industry ResearchMesalamine API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalamine API Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Mesalamine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalamine API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalamine API Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Mesalamine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesalamine API include Cambrex Corporation, Chemi SpA, Corden Pharma Bergamo, CTX Lifescience, Divis Laboratories, Erregierre SpA, Ipca Laboratories, Ishita Active Pharma Ingredients and Lasa Loboratory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Mesalamine API output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Mesalamine API by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Mesalamine API market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalamine API and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalamine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalamine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalamine API Segment by Company

Cambrex Corporation

Chemi SpA

Corden Pharma Bergamo

CTX Lifescience

Divis Laboratories

Erregierre SpA

Ipca Laboratories

Ishita Active Pharma Ingredients

Lasa Loboratory

PharmaZell

Syntese A/S

Hangzhou Brother

Lianyungang Fengheng Biopharm

YC Biotech (Jiangsu)

Mesalamine API Segment by Type

Purity ≥ 99%

Purity ≥ 98%

Purity ≥ 97%

Mesalamine API Segment by Application

Suppository

Tablets

Granule

Capsules

Enema

Others

Mesalamine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalamine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalamine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalamine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalamine API market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesalamine API industry.

Chapter 3: Detailed analysis of Mesalamine API market competition landscape. Including Mesalamine API manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Mesalamine API by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Mesalamine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Mesalamine API Industry Trends Table 2. Mesalamine API Industry Drivers Table 3. Mesalamine API Industry Opportunities and Challenges Table 4. Mesalamine API Industry Restraints Table 5. Global Mesalamine API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mesalamine API Production Value Share by Manufacturers (2021-2026) Table 7. Global Mesalamine API Production by Manufacturers (t) & (2021-2026) Table 8. Global Mesalamine API Production Market Share by Manufacturers Table 9. Global Mesalamine API Average Price (USD/kg) of Manufacturers (2021-2026) Table 10. Global Mesalamine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mesalamine API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mesalamine API Manufacturers, Product Type & Application Table 13. Global Mesalamine API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalamine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Purity ≥ 99% Table 17. Major Manufacturers of Purity ≥ 98% Table 18. Major Manufacturers of Purity ≥ 97% Table 19. Global Mesalamine API Production by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Mesalamine API Production by Type (2021-2026) & (t) Table 21. Global Mesalamine API Production by Type (2027-2032) & (t) Table 22. Global Mesalamine API Production Market Share by Type (2021-2026) Table 23. Global Mesalamine API Production Market Share by Type (2027-2032) Table 24. Global Mesalamine API Production Value by Type 2021 VS 2025 VS 2032 (t) Table 25. Global Mesalamine API Production Value by Type (2021-2026) & (t) Table 26. Global Mesalamine API Production Value by Type (2027-2032) & (t) Table 27. Global Mesalamine API Production Value Market Share by Type (2021-2026) Table 28. Global Mesalamine API Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Suppository Table 30. Major Manufacturers of Tablets Table 31. Major Manufacturers of Granule Table 32. Major Manufacturers of Capsules Table 33. Major Manufacturers of Enema Table 34. Major Manufacturers of Others Table 35. Global Mesalamine API Production by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Mesalamine API Production by Application (2021-2026) & (t) Table 37. Global Mesalamine API Production by Application (2027-2032) & (t) Table 38. Global Mesalamine API Production Market Share by Application (2021-2026) Table 39. Global Mesalamine API Production Market Share by Application (2027-2032) Table 40. Global Mesalamine API Production Value by Application 2021 VS 2025 VS 2032 (t) Table 41. Global Mesalamine API Production Value by Application (2021-2026) & (t) Table 42. Global Mesalamine API Production Value by Application (2027-2032) & (t) Table 43. Global Mesalamine API Production Value Market Share by Application (2021-2026) Table 44. Global Mesalamine API Production Value Market Share by Application (2027-2032) Table 45. Cambrex Corporation Company Information Table 46. Cambrex Corporation Business Overview Table 47. Cambrex Corporation Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 48. Cambrex Corporation Mesalamine API Product Portfolio Table 49. Cambrex Corporation Recent Development Table 50. Chemi SpA Company Information Table 51. Chemi SpA Business Overview Table 52. Chemi SpA Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 53. Chemi SpA Mesalamine API Product Portfolio Table 54. Chemi SpA Recent Development Table 55. Corden Pharma Bergamo Company Information Table 56. Corden Pharma Bergamo Business Overview Table 57. Corden Pharma Bergamo Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 58. Corden Pharma Bergamo Mesalamine API Product Portfolio Table 59. Corden Pharma Bergamo Recent Development Table 60. CTX Lifescience Company Information Table 61. CTX Lifescience Business Overview Table 62. CTX Lifescience Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 63. CTX Lifescience Mesalamine API Product Portfolio Table 64. CTX Lifescience Recent Development Table 65. Divis Laboratories Company Information Table 66. Divis Laboratories Business Overview Table 67. Divis Laboratories Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 68. Divis Laboratories Mesalamine API Product Portfolio Table 69. Divis Laboratories Recent Development Table 70. Erregierre SpA Company Information Table 71. Erregierre SpA Business Overview Table 72. Erregierre SpA Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 73. Erregierre SpA Mesalamine API Product Portfolio Table 74. Erregierre SpA Recent Development Table 75. Ipca Laboratories Company Information Table 76. Ipca Laboratories Business Overview Table 77. Ipca Laboratories Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 78. Ipca Laboratories Mesalamine API Product Portfolio Table 79. Ipca Laboratories Recent Development Table 80. Ishita Active Pharma Ingredients Company Information Table 81. Ishita Active Pharma Ingredients Business Overview Table 82. Ishita Active Pharma Ingredients Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 83. Ishita Active Pharma Ingredients Mesalamine API Product Portfolio Table 84. Ishita Active Pharma Ingredients Recent Development Table 85. Lasa Loboratory Company Information Table 86. Lasa Loboratory Business Overview Table 87. Lasa Loboratory Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 88. Lasa Loboratory Mesalamine API Product Portfolio Table 89. Lasa Loboratory Recent Development Table 90. PharmaZell Company Information Table 91. PharmaZell Business Overview Table 92. PharmaZell Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 93. PharmaZell Mesalamine API Product Portfolio Table 94. PharmaZell Recent Development Table 95. Syntese A/S Company Information Table 96. Syntese A/S Business Overview Table 97. Syntese A/S Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 98. Syntese A/S Mesalamine API Product Portfolio Table 99. Syntese A/S Recent Development Table 100. Hangzhou Brother Company Information Table 101. Hangzhou Brother Business Overview Table 102. Hangzhou Brother Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 103. Hangzhou Brother Mesalamine API Product Portfolio Table 104. Hangzhou Brother Recent Development Table 105. Lianyungang Fengheng Biopharm Company Information Table 106. Lianyungang Fengheng Biopharm Business Overview Table 107. Lianyungang Fengheng Biopharm Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 108. Lianyungang Fengheng Biopharm Mesalamine API Product Portfolio Table 109. Lianyungang Fengheng Biopharm Recent Development Table 110. YC Biotech (Jiangsu) Company Information Table 111. YC Biotech (Jiangsu) Business Overview Table 112. YC Biotech (Jiangsu) Mesalamine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 113. YC Biotech (Jiangsu) Mesalamine API Product Portfolio Table 114. YC Biotech (Jiangsu) Recent Development Table 115. Global Mesalamine API Production by Region: 2021 VS 2025 VS 2032 (t) Table 116. Global Mesalamine API Production by Region (2021-2026) & (t) Table 117. Global Mesalamine API Production Market Share by Region (2021-2026) Table 118. Global Mesalamine API Production Forecast by Region (2027-2032) & (t) Table 119. Global Mesalamine API Production Market Share Forecast by Region (2027-2032) Table 120. Global Mesalamine API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 121. Global Mesalamine API Production Value by Region (2021-2026) & (US$ Million) Table 122. Global Mesalamine API Production Value Share by Region (2021-2026) Table 123. Global Mesalamine API Production Value by Region (2027-2032) & (US$ Million) Table 124. Global Mesalamine API Production Value Share by Region: (2027-2032) & (US$ Million) Table 125. Global Mesalamine API Market Average Price (USD/kg) by Region (2021-2026) Table 126. Global Mesalamine API Market Average Price (USD/kg) by Region (2027-2032) Table 127. Global Mesalamine API Consumption by Region: 2021 VS 2025 VS 2032 (t) Table 128. Global Mesalamine API Consumption by Region (2021-2026) & (t) Table 129. Global Mesalamine API Consumption Market Share by Region (2021-2026) Table 130. Global Mesalamine API Consumption Forecasted by Region (2027-2032) & (t) Table 131. Global Mesalamine API Consumption Forecasted Market Share by Region (2027-2032) Table 132. North America Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 133. North America Mesalamine API Consumption by Country (2021-2026) & (t) Table 134. North America Mesalamine API Consumption by Country (2027-2032) & (t) Table 135. Europe Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 136. Europe Mesalamine API Consumption by Country (2021-2026) & (t) Table 137. Europe Mesalamine API Consumption by Country (2027-2032) & (t) Table 138. Asia Pacific Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 139. Asia Pacific Mesalamine API Consumption by Country (2021-2026) & (t) Table 140. Asia Pacific Mesalamine API Consumption by Country (2027-2032) & (t) Table 141. South America Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 142. South America Mesalamine API Consumption by Country (2021-2026) & (t) Table 143. South America Mesalamine API Consumption by Country (2027-2032) & (t) Table 144. Middle East & Africa Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 145. Middle East & Africa Mesalamine API Consumption by Country (2021-2026) & (t) Table 146. Middle East & Africa Mesalamine API Consumption by Country (2027-2032) & (t) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Mesalamine API Distributors List Table 150. Mesalamine API Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Mesalamine API Product Image Figure 2. Global Mesalamine API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalamine API Production Value (2021-2032) & (US$ Million) Figure 4. Global Mesalamine API Production Capacity (2021-2032) & (t) Figure 5. Global Mesalamine API Production (2021-2032) & (t) Figure 6. Global Mesalamine API Average Price (USD/kg) & (2021-2032) Figure 7. Global Top 5 and 10 Mesalamine API Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥ 99% Image Figure 10. Purity ≥ 98% Image Figure 11. Purity ≥ 97% Image Figure 12. Global Mesalamine API Production by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Mesalamine API Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global Mesalamine API Production Market Share by Type (2021-2032) Figure 15. Global Mesalamine API Production Value by Type (2021 VS 2025 VS 2032) & (t) Figure 16. Global Mesalamine API Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mesalamine API Production Value Share by Type (2021-2032) Figure 18. Suppository Image Figure 19. Tablets Image Figure 20. Granule Image Figure 21. Capsules Image Figure 22. Enema Image Figure 23. Others Image Figure 24. Global Mesalamine API Production by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Mesalamine API Production Market Share 2021 VS 2025 VS 2032 Figure 26. Global Mesalamine API Production Market Share by Application (2021-2032) Figure 27. Global Mesalamine API Production Value by Application (2021 VS 2025 VS 2032) & (t) Figure 28. Global Mesalamine API Production Value Share 2021 VS 2025 VS 2032 Figure 29. Global Mesalamine API Production Value Share by Application (2021-2032) Figure 30. Global Mesalamine API Production by Region: 2021 VS 2025 VS 2032 (t) Figure 31. Global Mesalamine API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Mesalamine API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Mesalamine API Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Mesalamine API Production Value (2021-2032) & (US$ Million) Figure 35. Europe Mesalamine API Production Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Mesalamine API Production Value (2021-2032) & (US$ Million) Figure 37. South America Mesalamine API Production Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Mesalamine API Production Value (2021-2032) & (US$ Million) Figure 39. North America Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 40. North America Mesalamine API Consumption Market Share by Country (2021-2032) Figure 41. U.S. Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 42. Canada Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 43. Mexico Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 44. Europe Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 45. Europe Mesalamine API Consumption Market Share by Country (2021-2032) Figure 46. Germany Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 47. France Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 48. U.K. Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 49. Italy Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 50. Netherlands Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 51. Asia Pacific Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 52. Asia Pacific Mesalamine API Consumption Market Share by Country (2021-2032) Figure 53. China Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 54. Japan Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 55. South Korea Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 56. Southeast Asia Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 57. India Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 58. Australia Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 59. South America Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 60. South America Mesalamine API Consumption Market Share by Country (2021-2032) Figure 61. Brazil Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 62. Argentina Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 63. Chile Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 64. Middle East & Africa Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 65. Middle East & Africa Mesalamine API Consumption Market Share by Country (2021-2032) Figure 66. Egypt Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 67. South Africa Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 68. Israel Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 69. Türkiye Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 70. GCC Countries Mesalamine API Consumption and Growth Rate (2021-2032) & (t) Figure 71. Mesalamine API Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Mesalamine API Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 99%
  • Purity ≥ 98%
  • Purity ≥ 97%
Applications
  • Suppository
  • Tablets
  • Granule
  • Capsules
  • Enema
  • Others
Companies covered
  • Cambrex Corporation
  • Chemi SpA
  • Corden Pharma Bergamo
  • CTX Lifescience
  • Divis Laboratories
  • Erregierre SpA
  • Ipca Laboratories
  • Ishita Active Pharma Ingredients
  • Lasa Loboratory
  • PharmaZell
  • Syntese A/S
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • YC Biotech (Jiangsu)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalamine API Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalamine API Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Mesalamine API Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Mesalamine API Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Mesalamine API Market Dynamics
  1. 2.1 Mesalamine API Industry Trends
  2. 2.2 Mesalamine API Industry Drivers
  3. 2.3 Mesalamine API Industry Opportunities and Challenges
  4. 2.4 Mesalamine API Industry Restraints
3 Mesalamine API Market by Manufacturers
  1. 3.1 Global Mesalamine API Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Mesalamine API Production by Manufacturers (2021-2026)
  3. 3.3 Global Mesalamine API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Mesalamine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalamine API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mesalamine API Manufacturers, Product Type & Application
  7. 3.7 Global Mesalamine API Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalamine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalamine API Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Mesalamine API Tier 1, Tier 2, and Tier 3
4 Mesalamine API Market by Type
  1. 4.1 Mesalamine API Type Introduction
  2. 4.1.1 Purity ≥ 99%
  3. 4.1.2 Purity ≥ 98%
  4. 4.1.3 Purity ≥ 97%
  5. 4.2 Global Mesalamine API Production by Type
  6. 4.2.1 Global Mesalamine API Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalamine API Production by Type (2021-2032)
  8. 4.2.3 Global Mesalamine API Production Market Share by Type (2021-2032)
  9. 4.3 Global Mesalamine API Production Value by Type
  10. 4.3.1 Global Mesalamine API Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalamine API Production Value by Type (2021-2032)
  12. 4.3.3 Global Mesalamine API Production Value Market Share by Type (2021-2032)
5 Mesalamine API Market by Application
  1. 5.1 Mesalamine API Application Introduction
  2. 5.1.1 Suppository
  3. 5.1.2 Tablets
  4. 5.1.3 Granule
  5. 5.1.4 Capsules
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalamine API Production by Application
  9. 5.2.1 Global Mesalamine API Production by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Mesalamine API Production by Application (2021-2032)
  11. 5.2.3 Global Mesalamine API Production Market Share by Application (2021-2032)
  12. 5.3 Global Mesalamine API Production Value by Application
  13. 5.3.1 Global Mesalamine API Production Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Mesalamine API Production Value by Application (2021-2032)
  15. 5.3.3 Global Mesalamine API Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cambrex Corporation
  2. 6.1.1 Cambrex Corporation Company Information
  3. 6.1.2 Cambrex Corporation Business Overview
  4. 6.1.3 Cambrex Corporation Mesalamine API Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Cambrex Corporation Mesalamine API Product Portfolio
  6. 6.1.5 Cambrex Corporation Recent Developments
  7. 6.2 Chemi SpA
  8. 6.2.1 Chemi SpA Company Information
  9. 6.2.2 Chemi SpA Business Overview
  10. 6.2.3 Chemi SpA Mesalamine API Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Chemi SpA Mesalamine API Product Portfolio
  12. 6.2.5 Chemi SpA Recent Developments
  13. 6.3 Corden Pharma Bergamo
  14. 6.3.1 Corden Pharma Bergamo Company Information
  15. 6.3.2 Corden Pharma Bergamo Business Overview
  16. 6.3.3 Corden Pharma Bergamo Mesalamine API Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Corden Pharma Bergamo Mesalamine API Product Portfolio
  18. 6.3.5 Corden Pharma Bergamo Recent Developments
  19. 6.4 CTX Lifescience
  20. 6.4.1 CTX Lifescience Company Information
  21. 6.4.2 CTX Lifescience Business Overview
  22. 6.4.3 CTX Lifescience Mesalamine API Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 CTX Lifescience Mesalamine API Product Portfolio
  24. 6.4.5 CTX Lifescience Recent Developments
  25. 6.5 Divis Laboratories
  26. 6.5.1 Divis Laboratories Company Information
  27. 6.5.2 Divis Laboratories Business Overview
  28. 6.5.3 Divis Laboratories Mesalamine API Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Divis Laboratories Mesalamine API Product Portfolio
  30. 6.5.5 Divis Laboratories Recent Developments
  31. 6.6 Erregierre SpA
  32. 6.6.1 Erregierre SpA Company Information
  33. 6.6.2 Erregierre SpA Business Overview
  34. 6.6.3 Erregierre SpA Mesalamine API Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Erregierre SpA Mesalamine API Product Portfolio
  36. 6.6.5 Erregierre SpA Recent Developments
  37. 6.7 Ipca Laboratories
  38. 6.7.1 Ipca Laboratories Company Information
  39. 6.7.2 Ipca Laboratories Business Overview
  40. 6.7.3 Ipca Laboratories Mesalamine API Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Ipca Laboratories Mesalamine API Product Portfolio
  42. 6.7.5 Ipca Laboratories Recent Developments
  43. 6.8 Ishita Active Pharma Ingredients
  44. 6.8.1 Ishita Active Pharma Ingredients Company Information
  45. 6.8.2 Ishita Active Pharma Ingredients Business Overview
  46. 6.8.3 Ishita Active Pharma Ingredients Mesalamine API Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Ishita Active Pharma Ingredients Mesalamine API Product Portfolio
  48. 6.8.5 Ishita Active Pharma Ingredients Recent Developments
  49. 6.9 Lasa Loboratory
  50. 6.9.1 Lasa Loboratory Company Information
  51. 6.9.2 Lasa Loboratory Business Overview
  52. 6.9.3 Lasa Loboratory Mesalamine API Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Lasa Loboratory Mesalamine API Product Portfolio
  54. 6.9.5 Lasa Loboratory Recent Developments
  55. 6.10 PharmaZell
  56. 6.10.1 PharmaZell Company Information
  57. 6.10.2 PharmaZell Business Overview
  58. 6.10.3 PharmaZell Mesalamine API Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 PharmaZell Mesalamine API Product Portfolio
  60. 6.10.5 PharmaZell Recent Developments
  61. 6.11 Syntese A/S
  62. 6.11.1 Syntese A/S Company Information
  63. 6.11.2 Syntese A/S Business Overview
  64. 6.11.3 Syntese A/S Mesalamine API Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Syntese A/S Mesalamine API Product Portfolio
  66. 6.11.5 Syntese A/S Recent Developments
  67. 6.12 Hangzhou Brother
  68. 6.12.1 Hangzhou Brother Company Information
  69. 6.12.2 Hangzhou Brother Business Overview
  70. 6.12.3 Hangzhou Brother Mesalamine API Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Hangzhou Brother Mesalamine API Product Portfolio
  72. 6.12.5 Hangzhou Brother Recent Developments
  73. 6.13 Lianyungang Fengheng Biopharm
  74. 6.13.1 Lianyungang Fengheng Biopharm Company Information
  75. 6.13.2 Lianyungang Fengheng Biopharm Business Overview
  76. 6.13.3 Lianyungang Fengheng Biopharm Mesalamine API Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 Lianyungang Fengheng Biopharm Mesalamine API Product Portfolio
  78. 6.13.5 Lianyungang Fengheng Biopharm Recent Developments
  79. 6.14 YC Biotech (Jiangsu)
  80. 6.14.1 YC Biotech (Jiangsu) Company Information
  81. 6.14.2 YC Biotech (Jiangsu) Business Overview
  82. 6.14.3 YC Biotech (Jiangsu) Mesalamine API Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 YC Biotech (Jiangsu) Mesalamine API Product Portfolio
  84. 6.14.5 YC Biotech (Jiangsu) Recent Developments
7 Global Mesalamine API Production by Region
  1. 7.1 Global Mesalamine API Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesalamine API Production by Region (2021-2032)
  3. 7.2.1 Global Mesalamine API Production by Region (2021-2026)
  4. 7.2.2 Global Mesalamine API Production Forecast by Region (2027-2032)
  5. 7.3 Global Mesalamine API Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Mesalamine API Production Value by Region (2021-2032)
  7. 7.4.1 Global Mesalamine API Production Value by Region (2021-2026)
  8. 7.4.2 Global Mesalamine API Production Value by Region (2027-2032)
  9. 7.5 Global Mesalamine API Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Mesalamine API Production Value (2021-2032)
  12. 7.6.2 Europe Mesalamine API Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Mesalamine API Production Value (2021-2032)
  14. 7.6.4 South America Mesalamine API Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Mesalamine API Production Value (2021-2032)
8 Global Mesalamine API Consumption by Region
  1. 8.1 Global Mesalamine API Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Mesalamine API Consumption by Region (2021-2032)
  3. 8.2.1 Global Mesalamine API Consumption by Region (2021-2026)
  4. 8.2.2 Global Mesalamine API Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Mesalamine API Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Mesalamine API Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Mesalamine API Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Mesalamine API Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Mesalamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Mesalamine API Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalamine API Value Chain Analysis
  2. 9.1.1 Mesalamine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalamine API Production Mode & Process
  6. 9.2 Mesalamine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalamine API Distributors
  9. 9.2.3 Mesalamine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst